Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions

Molecular Therapy

Volumn 19, Issue 8, 2011, Pages 1433-1439

  Peters, Tricia L ^a   Mcclain, Kenneth L ^a   Allen, Carl E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; INTERLEUKIN 17; MESSENGER RNA;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; CELL LYSATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HISTIOCYTOSIS X; HUMAN; HUMAN CELL; HUMAN TISSUE; IL 17A GENE; PATHOGENESIS; PROTEIN DETERMINATION;

EID: 79961032355     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.106     Document Type: Article

References (30)

1. Aricò, M, Girschikofsky, M, Généreau, T, Klersy, C, McClain, K, Grois, N et al. (2003). Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 39: 2341-2348. (Pubitemid 37214858)
2. Baumgartner, I, von Hochstetter, A, Baumert, B, Luetolf, U and Follath, F (1997). Langerhans'-cell histiocytosis in adults. Med Pediatr Oncol 28: 9-14. (Pubitemid 27023770)
3. Carstensen, H and Ornvold, K (1993). [Langerhans-cell histiocytosis (histiocytosis X) in children]. Ugeskr Laeg 155: 1779-1783.
4. Ornvold, K, Ralfkiaer, E and Carstensen, H (1990). Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (histiocytosis x). Virchows Arch A Pathol Anat Histopathol 416: 403-410. (Pubitemid 20099783)
5. Chikwava, K and Jaffe, R (2004). Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Pediatr Dev Pathol 7: 607-614.
6. Lau, SK, Chu, PG and Weiss, LM (2008). Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol 32: 615-619. (Pubitemid 351458304)
7. Nezelof, C, Basset, F and Rousseau, MF (1973). Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine 18: 365-371.
8. Allen, CE, Li, L, Peters, TL, Leung, HC, Yu, A, Man, TK et al. (2010). Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 184: 4557-4567.
9. Merad, M, Ginhoux, F and Collin, M (2008). Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8: 935-947.
10. Arceci, RJ (1999). The histiocytoses: the fall of the Tower of Babel. Eur J Cancer 35: 747-67; discussion 767.
11. Egeler, RM, Annels, NE and Hogendoorn, PC (2004). Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation. Pediatr Blood Cancer 42: 401-403. (Pubitemid 38524467)
12. Fadeel, B and Henter, JI (2003). Langerhans-cell histiocytosis: neoplasia or unbridled inflammation? Trends Immunol 24: 409-10; author reply 410.
13. Laman, JD, Leenen, PJ, Annels, NE, Hogendoorn, PC and Egeler, RM (2003). Langerhans-cell histiocytosis 'insight into DC biology'. Trends Immunol 24: 190-196.
14. Coury, F, Annels, N, Rivollier, A, Olsson, S, Santoro, A, Speziani, C et al. (2008). Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat Med 14: 81-87.
15. Miossec, P, Korn, T and Kuchroo, VK (2009). Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898.
16. Pappu, R, Ramirez-Carrozzi, V, Ota, N, Ouyang, W and Hu, Y (2010). The IL-17 family cytokines in immunity and disease. J Clin Immunol 30: 185-195.
17. Zou, W and Restifo, NP (2010). T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 10: 248-256.
18. Ivanov, S and Lindén, A (2009). Interleukin-17 as a drug target in human disease. Trends Pharmacol Sci 30: 95-103.
19. Sarkar, S and Fox, DA (2010). Targeting IL-17 and Th17 cells in rheumatoid arthritis. Rheum Dis Clin North Am 36: 345-366.
20. Segal, BM (2010). Th17 cells in autoimmune demyelinating disease. Semin Immunopathol 32: 71-77.
21. Grois, N, Prayer, D, Prosch, H and Lassmann, H; CNS LCH Co-operative Group (2005). Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain 128(Pt 4): 829-838. (Pubitemid 40516920)
22. Egeler, RM, van Halteren, AG, Hogendoorn, PC, Laman, JD and Leenen, PJ (2010). Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage. Immunol Rev 234: 213-232.
23. Gavhed, D, Akefeldt, SO, Osterlundh, G, Laurencikas, E, Hjorth, L, Blennow, K et al. (2009). Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis. Pediatr Blood Cancer 53: 1264-1270.
24. Nichols, KE and Arceci, RJ (2010). BRAF, a piece of the LCH puzzle. Blood 116: 1825-1827.
25. Genovese, MC, Van den Bosch, F, Roberson, SA, Bojin, S, Biagini, IM, Ryan, P et al. (2010). LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 62: 929-939.
26. Hueber, W, Patel, DD, Dryja, T, Wright, AM, Koroleva, I, Bruin, G et al.; Psoriasis Study Group; Rheumatoid Arthritis Study Group; Uveitis Study Group. (2010). Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med 2: 52ra72.
27. Allen, CE and McClain, KL (2009). Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nat Med 15: 483-4; author reply 484.
28. Cupedo, T, Crellin, NK, Papazian, N, Rombouts, EJ, Weijer, K, Grogan, JL et al. (2009). Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10: 66-74.
29. Blumberg, RS, Gerdes, D, Chott, A, Porcelli, SA and Balk, SP (1995). Structure and function of the CD1 family of MHC-like cell surface proteins. Immunol Rev 147: 5-29.
30. Gadner, H, Grois, N, Pötschger, U, Minkov, M, Aricò, M, Braier, J et al.; Histiocyte Society. (2008). Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 111: 2556-2562.